1. Home
  2. SANG vs TIL Comparison

SANG vs TIL Comparison

Compare SANG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

N/A

Current Price

$5.37

Market Cap

170.0M

Sector

Technology

ML Signal

N/A

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$10.85

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANG
TIL
Founded
1984
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.0M
177.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SANG
TIL
Price
$5.37
$10.85
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$100.67
AVG Volume (30 Days)
4.8K
69.7K
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$227,360,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$10.70
52 Week High
$7.99
$42.79

Technical Indicators

Market Signals
Indicator
SANG
TIL
Relative Strength Index (RSI) 56.96 36.08
Support Level $5.07 $10.76
Resistance Level $5.42 $11.51
Average True Range (ATR) 0.13 0.73
MACD 0.03 0.16
Stochastic Oscillator 91.26 2.71

Price Performance

Historical Comparison
SANG
TIL

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: